- This event has passed.
On the Therapeutic Applications of Ketamine [ONLINE]
March 4 @ 7:00 pm - 8:00 pm
The field of psychedelic-assisted psychotherapy has been growing rapidly in recent years with decriminalization efforts moving forward on local, state, and federal levels. A multitude of clinical research trials is showing promising results of therapies utilizing MDMA, psilocybin, and ketamine as well as other medicines in the treatment of trauma, depression, addiction, end-of-life, and other mental health conditions.
Ketamine was first developed in the 1960s as a surgical anesthetic for humans. In recent years, it was discovered that ketamine also has rapid acting anti-depressant and anti-obsessional properties. Ketamine also induces dissociative and mystical experiences when used in a particular way. In the last few years, there has been a tremendous amount of interest in the use of ketamine for psychiatric indications, psychological work, and psycho-spiritual exploration. An entire new industry has sprung up around ketamine, including new treatment options for psychiatric patients, keen interest from investors, and curiosity from psychedelic explorers.
Join clinician and CIIS professor Gisele Fernandes-Osterhold for a conversation with psychologist Raquel Bennett about the exploding field of therapeutic ketamine.